These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38310713)

  • 1. The construction and immunogenicity analyses of a recombinant pseudorabies virus with Senecavirus A VP3 protein co-expression.
    Tao Q; Xu L; Zhang Y; Yang Y; Liu Z; Xu T; Lai S; Ai Y; Zhu L; Xu Z
    Vet Microbiol; 2024 Mar; 290():110011. PubMed ID: 38310713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression.
    Tao Q; Zhu L; Xu L; Yang Y; Zhang Y; Liu Z; Xu T; Wen J; Deng L; Zhou Y; Xu Z
    Microbiol Spectr; 2023 Mar; 11(2):e0522922. PubMed ID: 36976021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the Cap protein of porcine circovirus type 2d.
    Xu RQ; Wang LQ; Zheng HH; Tian RB; Zheng LL; Ma SJ; Chen HY
    Comp Immunol Microbiol Infect Dis; 2023 Oct; 101():102054. PubMed ID: 37651789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of an attenuated Chinese pseudorabies variant by dual deletion of TK&gE genes.
    Wang J; Song Z; Ge A; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Zheng Y; Fan H; Hou J
    BMC Vet Res; 2018 Sep; 14(1):287. PubMed ID: 30241529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and immunogenicity of a gE/gI/TK-deleted PRV based on porcine pseudorabies virus variant.
    Zhao Y; Wang LQ; Zheng HH; Yang YR; Liu F; Zheng LL; Jin Y; Chen HY
    Mol Cell Probes; 2020 Oct; 53():101605. PubMed ID: 32464159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better immune efficacy triggered by the inactivated gI/gE-deleted pseudorabies virus with the additional insertion of gC gene in mice and weaned pigs.
    Yan Z; Chen M; Tang D; Wu X; Ren X; Pan H; Li Y; Ji Q; Luo Y; Fan H; Ju C
    Virus Res; 2021 Apr; 296():198353. PubMed ID: 33640358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant.
    Xu M; Zhang C; Liu Y; Chen S; Zheng Y; Wang Z; Cao R; Wang J
    Virus Res; 2022 May; 313():198740. PubMed ID: 35271886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6.
    Zheng HH; Wang LQ; Fu PF; Zheng LL; Chen HY; Liu F
    Virol J; 2020 Feb; 17(1):19. PubMed ID: 32014014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs.
    Lei JL; Xia SL; Wang Y; Du M; Xiang GT; Cong X; Luo Y; Li LF; Zhang L; Yu J; Hu Y; Qiu HJ; Sun Y
    Immunol Lett; 2016 Jun; 174():63-71. PubMed ID: 27113530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of recombinant pseudorabies virus expressing PCV2 Cap, PCV3 Cap, and IL-4: investigation of their biological characteristics and immunogenicity.
    Yang Y; Xu Z; Tao Q; Xu L; Gu S; Huang Y; Liu Z; Zhang Y; Wen J; Lai S; Zhu L
    Front Immunol; 2024; 15():1339387. PubMed ID: 38571947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive evaluation of the safety and immunogenicity of a gene-deleted variant pseudorabies virus attenuated vaccine.
    Li L; Du Y; Zhang Y; Li P; Liu X; Zhang X; Li J; Zhang T; Li X; Xiao D; Liu P; Qi P; Xiao J
    Vet Res; 2022 Sep; 53(1):73. PubMed ID: 36138470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The construction and immunogenicity analyses of a recombinant pseudorabies virus with porcine circovirus type 3 capsid protein co-expression.
    Yao L; Cheng Y; Wu H; Ghonaim AH; Fan S; Li W; He Q
    Vet Microbiol; 2022 Jan; 264():109283. PubMed ID: 34902738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A live gI/gE-deleted pseudorabies virus (PRV) protects weaned piglets against lethal variant PRV challenge.
    Yin Y; Xu Z; Liu X; Li P; Yang F; Zhao J; Fan Y; Sun X; Zhu L
    Virus Genes; 2017 Aug; 53(4):565-572. PubMed ID: 28417300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV.
    Tong W; Zheng H; Li GX; Gao F; Shan TL; Zhou YJ; Yu H; Jiang YF; Yu LX; Li LW; Kong N; Tong GZ; Li JC
    Antiviral Res; 2020 Jan; 173():104652. PubMed ID: 31751590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
    Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
    Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Construction and Immunogenicity Analyses of Recombinant Pseudorabies Virus With NADC30-Like Porcine Reproductive and Respiratory Syndrome Virus-Like Particles Co-expression.
    Zhao J; Zhu L; Xu L; Li F; Deng H; Huang Y; Gu S; Sun X; Zhou Y; Xu Z
    Front Microbiol; 2022; 13():846079. PubMed ID: 35308386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Pseudorabies virus vaccine developed using HDR-CRISPR/Cas9 induces strong humoral and cellular immune response in mice.
    Luo C; Wang Q; Guo R; Zhang J; Zhang J; Zhang R; Ma X; Wang P; Adam FEA; Zeshan B; Yang Z; Zhou Y; Wang X
    Virus Res; 2022 Dec; 322():198937. PubMed ID: 36174845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
    Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
    Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant pseudorabies virus with gI/gE deletion generated by overlapping polymerase chain reaction and homologous recombination technology induces protection against the PRV variant PRV-GD2013.
    Li W; Zhuang D; Li H; Zhao M; Zhu E; Xie B; Chen J; Zhao M
    BMC Vet Res; 2021 Apr; 17(1):164. PubMed ID: 33853597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the protective efficacy between the candidate vaccine ZJ01R carrying gE/gI/TK deletion and three commercial vaccines against an emerging pseudorabies virus variant.
    Jiang C; Ma Z; Bai J; Sun Y; Cao M; Wang X; Jiang P; Liu X
    Vet Microbiol; 2023 Jan; 276():109623. PubMed ID: 36495739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.